Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Medtronic
Harvard Business School
Dow
McKesson

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR TASIMELTEON


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Tasimelteon

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01163032 ↗ Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder Completed Vanda Pharmaceuticals Phase 3 2010-08-01 The purpose of this study is to evaluate the efficacy and safety of a six month double-mask treatment of tasimelteon or placebo in male and female subjects with Non-24-Hour Sleep-Wake Disorder
NCT01218789 ↗ Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception Unknown status Vanda Pharmaceuticals Phase 3 2010-09-01 The purpose of this study is to evaluate the safety of a one year open-label treatment of tasimelteon in male and female subjects with Non-24-Hour Sleep-Wake Disorder.
NCT01271387 ↗ Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment Completed Vanda Pharmaceuticals Phase 1 2011-01-01 The purpose of this research study is to understand whether there is any difference in the amount of tasimelteon (including its breakdown products) in the blood in individuals with mild or moderate liver disease compared to individuals who have normal liver function.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Tasimelteon

Condition Name

Condition Name for Tasimelteon
Intervention Trials
Non-24-Hour Sleep-Wake Disorder 3
Healthy Volunteers 3
Smith-Magenis Syndrome 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Tasimelteon
Intervention Trials
Disease 8
Sleep Wake Disorders 7
Sleep Disorders, Circadian Rhythm 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Tasimelteon

Trials by Country

Trials by Country for Tasimelteon
Location Trials
United States 107
Lebanon 1
Germany 1
Canada 1
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Tasimelteon
Location Trials
Maryland 9
California 8
Missouri 8
Florida 7
Texas 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Tasimelteon

Clinical Trial Phase

Clinical Trial Phase for Tasimelteon
Clinical Trial Phase Trials
Phase 4 1
Phase 3 7
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Tasimelteon
Clinical Trial Phase Trials
Completed 14
Unknown status 4
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Tasimelteon

Sponsor Name

Sponsor Name for Tasimelteon
Sponsor Trials
Vanda Pharmaceuticals 18
Saint-Joseph University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Tasimelteon
Sponsor Trials
Industry 18
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
AstraZeneca
McKinsey
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.